Company intelligence / Profile preview
Kelun Pharmaceutical
Chengdu, Sichuan Province, Chinaen.kelun.com ↗
- Ownership
- Public · 002422.SZ
- Employees
- ~20000
- Development stage
- Commercial
01
Overview
Kelun has a broad commercial portfolio of IV solutions/antibiotics with global reach. Its biotech arm is advancing over thirty innovative drug candidates—including more than ten clinical-stage ADCs—targeting prevalent cancers and other high-burden diseases. Notable filings include sacituzumab tirumotecan for EGFR-mutated NSCLC and triple-negative breast cancer in China. Multiple global partnerships validate its R&D capabilities.
- Therapeutic areas
- OncologyMetabolic DisordersImmunologyGastroenterologyInfectious Diseases
- Modalities
- Antibody-drug conjugateMonoclonal antibodyBispecific monoclonal antibodySmall moleculeBiologicsAPIs
- Industry
- Pharma
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
Merck & Co. (Multi-program global collaboration/licensing deal focused on ADCs)
04
Financials
- Market cap
- $9.7B
- Total revenue
- $2.8B
- Enterprise value
- $8.7B
Beyond the preview
Go deeper on Kelun Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kelun Pharmaceutical.